Suppr超能文献

评估 COVID-19 疫苗犹豫、信心和公众参与:一项全球社会聆听研究。

Assessing COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: A Global Social Listening Study.

机构信息

School of Public Health, Fudan University, Shanghai, China.

National Health Commission Key Laboratory of Health Technology Assessment, Fudan University, Shanghai, China.

出版信息

J Med Internet Res. 2021 Jun 11;23(6):e27632. doi: 10.2196/27632.

Abstract

BACKGROUND

Monitoring public confidence and hesitancy is crucial for the COVID-19 vaccine rollout. Social media listening (infoveillance) can not only monitor public attitudes on COVID-19 vaccines but also assess the dissemination of and public engagement with these opinions.

OBJECTIVE

This study aims to assess global hesitancy, confidence, and public engagement toward COVID-19 vaccination.

METHODS

We collected posts mentioning the COVID-19 vaccine between June and July 2020 on Twitter from New York (United States), London (United Kingdom), Mumbai (India), and Sao Paulo (Brazil), and Sina Weibo posts from Beijing (China). In total, we manually coded 12,886 posts from the five global metropolises with high COVID-19 burdens, and after assessment, 7032 posts were included in the analysis. We manually double-coded these posts using a coding framework developed according to the World Health Organization's Confidence, Complacency, and Convenience model of vaccine hesitancy, and conducted engagement analysis to investigate public communication about COVID-19 vaccines on social media.

RESULTS

Among social media users, 36.4% (571/1568) in New York, 51.3% (738/1440) in London, 67.3% (144/214) in Sao Paulo, 69.8% (726/1040) in Mumbai, and 76.8% (2128/2770) in Beijing indicated that they intended to accept a COVID-19 vaccination. With a high perceived risk of getting COVID-19, more tweeters in New York and London expressed a lack of confidence in vaccine safety, distrust in governments and experts, and widespread misinformation or rumors. Tweeters from Mumbai, Sao Paulo, and Beijing worried more about vaccine production and supply, whereas tweeters from New York and London had more concerns about vaccine distribution and inequity. Negative tweets expressing lack of vaccine confidence and misinformation or rumors had more followers and attracted more public engagement online.

CONCLUSIONS

COVID-19 vaccine hesitancy is prevalent worldwide, and negative tweets attract higher engagement on social media. It is urgent to develop an effective vaccine campaign that boosts public confidence and addresses hesitancy for COVID-19 vaccine rollouts.

摘要

背景

监测公众信心和犹豫对于 COVID-19 疫苗的推广至关重要。社交媒体监测(infoveillance)不仅可以监测公众对 COVID-19 疫苗的态度,还可以评估这些观点的传播和公众参与度。

目的

本研究旨在评估全球对 COVID-19 疫苗接种的犹豫、信心和公众参与度。

方法

我们于 2020 年 6 月至 7 月期间在 Twitter 上从纽约(美国)、伦敦(英国)、孟买(印度)和圣保罗(巴西)以及新浪微博上从北京(中国)收集了提及 COVID-19 疫苗的帖子。总共,我们对五个具有高 COVID-19 负担的全球大都市的 12886 条帖子进行了手动编码,经过评估,有 7032 条帖子被纳入分析。我们使用根据世界卫生组织的疫苗犹豫信心、自满和便利性模型制定的编码框架对这些帖子进行了手动双重编码,并进行了参与度分析,以调查社交媒体上公众对 COVID-19 疫苗的沟通情况。

结果

在社交媒体用户中,纽约有 36.4%(571/1568)、伦敦有 51.3%(738/1440)、圣保罗有 67.3%(144/214)、孟买有 69.8%(726/1040)和北京有 76.8%(2128/2770)表示他们打算接受 COVID-19 疫苗接种。由于对感染 COVID-19 的风险感知较高,更多的纽约和伦敦推特用户表示对疫苗安全性缺乏信心、对政府和专家的不信任以及广泛的错误信息或谣言。来自孟买、圣保罗和北京的推特用户更担心疫苗的生产和供应,而来自纽约和伦敦的推特用户则更担心疫苗的分配和不公平问题。表达对疫苗缺乏信心和错误信息或谣言的负面推文拥有更多的关注者并在线上吸引了更多的公众参与。

结论

全球范围内 COVID-19 疫苗犹豫普遍存在,负面推文在社交媒体上吸引了更高的关注度。当务之急是制定一项有效的疫苗推广活动,以增强公众对 COVID-19 疫苗的信心,并解决疫苗犹豫问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5faa/8202656/7549410991e2/jmir_v23i6e27632_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验